Researcher.Life Logo

ACS Chemical Neuroscience : Impact Factor & More

eISSN: 1948-7193pISSN: 1948-7193

Aims and Scope of ACS Chemical Neuroscience

ACS Chemical Neuroscience is a peer-reviewed scientific journal published by the American Chemical Society. It covers research on the molecular underpinnings of nerve function in organisms and animal models. The journal was established in January 2010. The journal is one of the first journals of the American Chemical Society to be available in online-only format. The founding editor-in-chief is Craig W. Lindsley (Vanderbilt University). Less

Key Metrics

CiteScore
7.7
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SJR
Q2Physiology
SNIP
1.08
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ACS Chemical Neuroscience

ACS Chemical Neuroscience Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER CHEMICAL SOC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ACS Chemical Neuroscience ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ACS Chemical Neuroscience

Profiling Endogenous Opioid Peptide Release from Adrenal Chromaffin Cells.
  • 20 May 2026
  • ACS chemical neuroscience
Varenicline as a DREADD Actuator Elicits Off-Target Effects on Somatosensation, Locomotion, and Anxiety-Related Behaviors in Rats.
  • 20 May 2026
  • ACS chemical neuroscience
Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice.
  • 20 May 2026
  • ACS chemical neuroscience
Longitudinal PET Imaging of the Effects of a D2 Dopamine Receptor Antisense Oligonucleotide.
  • 20 May 2026
  • ACS chemical neuroscience
Fragmentation-Induced Disassembly and Reaggregation of Α-Synuclein Amyloid Fibrils.
  • 20 May 2026
  • ACS chemical neuroscience
Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models.
  • 20 May 2026
  • ACS chemical neuroscience
Profiling Endogenous Opioid Peptide Release from Adrenal Chromaffin Cells.
  • 20 May 2026
  • ACS chemical neuroscience
Varenicline as a DREADD Actuator Elicits Off-Target Effects on Somatosensation, Locomotion, and Anxiety-Related Behaviors in Rats.
  • 20 May 2026
  • ACS chemical neuroscience
Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice.
  • 20 May 2026
  • ACS chemical neuroscience
Longitudinal PET Imaging of the Effects of a D2 Dopamine Receptor Antisense Oligonucleotide.
  • 20 May 2026
  • ACS chemical neuroscience
Fragmentation-Induced Disassembly and Reaggregation of Α-Synuclein Amyloid Fibrils.
  • 20 May 2026
  • ACS chemical neuroscience
Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models.
  • 20 May 2026
  • ACS chemical neuroscience

FAQs on ACS Chemical Neuroscience